Expand SGMO Menu
SGMO MENU

SGMO Stock Summary and Trading Ideas (Sangamo Therapeutics | NASDAQ:SGMO)

Charts for Today's Stock Price and Implied Volatility in Sangamo Therapeutics

18-Apr-2024

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for SGMO by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Sangamo Therapeutics (SGMO) Frequently Asked Questions

What does Sangamo Therapeutics do?

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

What symbol and exchange does Sangamo Therapeutics stock trade?

Sangamo Therapeutics trades on the NASDAQ stock market under the symbol SGMO.

What is Sangamo Therapeutics stock price doing today?

As of April 18, 2024, SGMO stock price declined to $0.49 with 1,699,471 million shares trading.

What is Sangamo Therapeutics's Beta?

SGMO has a beta of 1.95, meaning it tends to be more sensitive to market movements. SGMO has a correlation of 0.03 to the broad based SPY ETF.

How much is Sangamo Therapeutics worth?

SGMO has a market cap of $98.80 million. This is considered a Micro Cap stock.

How much money does Sangamo Therapeutics make?

Last quarter Sangamo Therapeutics reported $2 million in Revenue and -$.34 earnings per share. This fell short of revenue expectation by $-6 million and missed earnings estimates by -$.08.

What is the highest and lowest price Sangamo Therapeutics traded in the last 3 year period?

In the last 3 years, SGMO stock traded as high as $12.83 and as low as $.29.

What are the top ETFs holding Sangamo Therapeutics?

The top ETF exchange traded funds that SGMO belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.

Is Sangamo Therapeutics (SGMO) a good investment?

SGMO has underperformed the market in the last year with a price return of -72.1% while the SPY ETF gained +22.3%. However, in the short term, SGMO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +9.1% vs +6.1% return in SPY. But in the last 2 weeks, SGMO shares have been beat by the market, returning -20.5% compared to an SPY return of -3.8%.

What is the support and resistance for Sangamo Therapeutics (SGMO) stock price?

SGMO support price is $.47 and resistance is $.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SGMO stock will trade within this expected range on the day.